May 3, 2024 — Reports of first quarter business results from Novo Nordisk and Eli Lilly this week leave no room for doubt. The utilization of obesity treatment is growing at a rate that has caught both of these companies by surprise. Wegovy sales more than doubled in the first quarter of 2024. On top of that, new prescriptions […]
April 30, 2024 — Last week, the U.S. Senate launched an investigation into the high price of semaglutide, sold as Ozempic and Wegovy by Novo Nordisk. Yes, pressure on GLP-1 pricing is building and you can be confident there’s more to come. Senator Bernie Sanders chairs the Senate Committee on Health, Education, Labor, and Pensions, which is undertaking this […]
December 17, 2023 — “Are you sure you want an Ozempic pill?” In the Atlantic, Yasmin Tayag poses this question. Back in June people were bubbling with enthusiasm at the prospect of an oral small molecule – orforglipron – that might work as well as injectable semaglutide. But Tayag offers caution that we share. One size, one approach, for […]
